New asthma shot tested for safety in first human trials
NCT ID NCT05991661
Summary
This early-stage study tested the safety of a new injection called XKH001, which is being developed for asthma. Researchers gave 24 healthy volunteers either the drug or a placebo injection to see how their bodies handled it. The main goal was to check for side effects and see how the drug moves through the body, not to treat asthma symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Hospital of Jilin University Phase I Clinical Research Center
Changchun, Jilin, 130000, China
Conditions
Explore the condition pages connected to this study.